The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

In the latest New Jersey Vioxx trial, the jurors rendered a verdict in favor of the plaintiff, Frederick “Mike” Humeston, who took Vioxx prior to his death. In this bifurcated preceding designed only to address Merck’s potential liability, the New Jersey state court jury found that Merck & Company failed to warn about the dangers associated with Vioxx in causing cardiovascular risks and complications. A second phase of the trial is expected to begin Monday in order to determine what compensatory damages, if any, should be awarded to Humeston’s family in connection with his heart attack and death while using Vioxx. The second phase will also address Merck’s conduct and decisions in manufacturing the dangerous drug and whether any punitive damages should be awarded.

Comments for this article are closed.